MultiPlan Corporation
MPLN-WT
New York Stock Exchange0.00
USD
-0.01
- -
MultiPlan Corporation
MPLN-WT
(New York Stock Exchange)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Claritev Corporation (NYSE: CTEV), formerly MultiPlan Corporation, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry. Founded in 1980 and headquartered in McLean, Virginia, the company offers analytics-based services that utilize data-driven algorithms to detect claims overcharges, negotiate reimbursements, and reduce medical costs; network-based services including contracted discounts with healthcare providers, outsourced network development, and management; payment and revenue integrity services that identify and eliminate improper charges, restore underpaid premiums, and include medical and dental payment integrity; data and decision science services delivering descriptive, predictive, and prescriptive analytics for optimized benefit plan design, clinical outcomes, and total cost of care reduction; and business-to-business healthcare payments along with surprise billing services. Claritev serves over 700 healthcare payers such as national and regional insurers, Blue Cross Blue Shield plans, third-party administrators, self-insured employers, government health plans, and property and casualty insurers; more than 100,000 employers; 60 million consumers; and 1.4 million contracted providers nationwide. In February 2025, the company rebranded from MultiPlan to Claritev, relocated its headquarters to McLean, Virginia, shifted its ticker from MPLN to CTEV, and launched initiatives under its Vision 2030 transformation plan emphasizing technology modernization, AI integration, and data infrastructure enhancements; it completed a comprehensive debt refinancing in late 2024 extending maturities to 2029-2031 with $350 million in new revolving credit commitments and exchange offers supported by 78% of creditors; formed strategic partnerships including with Lantern in May 2025 to integrate BenInsights and HST Connect for surgical cost transparency and J2 Health for network optimization; and invested in Klaim, Inc. in 2025 to bolster provider capabilities.